Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) - Sanofi
People Moves EMEA: Deloitte, Oliver Wyman, Bain, Citi | Business Chief EMEA
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Brian Dennehy - Management Consultant | Bain & Company
Media Update
New Paths to Value Creation in Pharma | Bain & Company
Sanofi adds first vaccine candidate against acne to its R&D pipeline with the take over of an Austrian privately held biotechnology firm | EuropaWire.eu | The European Union's press release distribution &
Provention Bio | Investor Relations - News
Sanofi revises fitusiran dosing to cut risk of thrombotic events in hemophilia phase 3 | Fierce Biotech
Media Contacts - Sanofi
Sanofi Goes Big with $1 Billion Immuno-Oncology Buy | BioSpace
Media Contacts - Sanofi
Sanofi makes $3.2B bet on mRNA by acquiring partner Translate Bio - Boston Business Journal
Sally Bain - Senior Director, Global Media Relations - Sanofi | LinkedIn
Ron Renaud | Bain Capital
Media Contacts - Sanofi
Nicolas Dumas - Management Consultant | Bain & Company
